Viewing Study NCT00139620


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:19 AM
Study NCT ID: NCT00139620
Status: COMPLETED
Last Update Posted: 2018-02-08
First Post: 2005-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function
Sponsor: OSI Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module